Literature DB >> 16789153

Marek's Disease Herpesviruses II. Purification and Further Characterization of Marek's Disease Herpesvirus A Antigen.

P A Long1, J L Clark, L F Velicer.   

Abstract

Marek's disease herpesvirus A antigen was purified greater than 200-fold with a 24% recovery by ion exchange column chromatography, isoelectric focusing, and preparative polyacrylamide gel electrophoresis. The antigen had an isoelectric point of 6.68 +/- 0.03 in the presence of 1 M urea and 0.05% Brij 35, a nonionic detergent, and approximately 6.5 in the absence of dissociating agents. When analyzed by electrophoresis on analytical polyacrylamide gels, the purified antigen migrated as a single broad band which stained for both protein and carbohydrate, suggesting that it was a highly purified heterogeneous glycoprotein. However, the antigen was not purified to homogeneity as determined by electrophoresis on polyacrylamide gels in the presence of sodium dodecyl sulfate and by immunodiffusion analysis. Antibody to Marek's disease herpesvirus A antigen was prepared in a rabbit, and antibody to two contaminating antigens was removed by adsorption to yield monospecific antisera.

Entities:  

Year:  1975        PMID: 16789153      PMCID: PMC354574     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  High specific activity iodination of gamma-globulin with iodine-131 monochloride.

Authors:  R W HELMKAMP; R L GOODLAND; W F BALE; I L SPAR; L E MUTSCHLER
Journal:  Cancer Res       Date:  1960-11       Impact factor: 12.701

3.  Marek's Disease Herpesviruses I. Production and Preliminary Characterization of Marek's Disease Herpesvirus A Antigen.

Authors:  P A Long; P Kaveh-Yamini; L F Velicer
Journal:  J Virol       Date:  1975-05       Impact factor: 5.103

4.  Immunoferritin studies of Marek's disease virus directed intracellular and membrane antigens.

Authors:  K Nazerian; J H Chen
Journal:  Arch Gesamte Virusforsch       Date:  1973

5.  Properties of feline leukemia virus. II. In vitro labeling of the polypeptides.

Authors:  L F Velicer; D C Graves
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

6.  Isolation and characterization of proteins from Rous sarcoma virus.

Authors:  P P Hung; H L Robinson; W S Robinson
Journal:  Virology       Date:  1971-01       Impact factor: 3.616

7.  Purification and properties of the 'A' antigen associated with Marek's disease virus infections.

Authors:  L J Ross; P M Biggs; A A Newton
Journal:  J Gen Virol       Date:  1973-03       Impact factor: 3.891

8.  Effect of nonionic detergent on fractionation of proteins by isoelectric focusing.

Authors:  A D Friesen; J C Jamieson; F E Ashton
Journal:  Anal Biochem       Date:  1971-05       Impact factor: 3.365

9.  Radioactive labeling of proteins in vitro.

Authors:  R H Rice; G E Means
Journal:  J Biol Chem       Date:  1971-02-10       Impact factor: 5.157

10.  Properties of feline leukemia virus. I. Chromatographic separation and analysis of the polypeptides.

Authors:  D C Graves; L F Velicer
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

View more
  12 in total

1.  Marek's Disease Herpesviruses I. Production and Preliminary Characterization of Marek's Disease Herpesvirus A Antigen.

Authors:  P A Long; P Kaveh-Yamini; L F Velicer
Journal:  J Virol       Date:  1975-05       Impact factor: 5.103

2.  Identification of the gene encoding Marek's disease herpesvirus A antigen.

Authors:  R J Isfort; H J Kung; L F Velicer
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

3.  Synthesis, processing, and secretion of the Marek's disease herpesvirus A antigen glycoprotein.

Authors:  R J Isfort; R A Stringer; H J Kung; L F Velicer
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

4.  Marke's disease herpesviruses. III. Purification and characterization of Marek's disease herpesvirus B antigen.

Authors:  L F Velicer; D R Yager; J L Clark
Journal:  J Virol       Date:  1978-07       Impact factor: 5.103

5.  Marek's disease herpesviruses. IV. Molecular characterization of Marek's disease herpesvirus A antigen.

Authors:  C Glaubiger; K Nazerian; L F Velicer
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

6.  Marek's disease virus gene clones encoding virus-specific phosphorylated polypeptides and serological characterization of fusion proteins.

Authors:  Z Z Cui; D Yan; L F Lee
Journal:  Virus Genes       Date:  1990-04       Impact factor: 2.332

7.  Molecular characterization of Marek's disease herpesvirus B antigen.

Authors:  R J Isfort; I Sithole; H J Kung; L F Velicer
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

8.  Extensive homology exists between Marek disease herpesvirus and its vaccine virus, herpesvirus of turkeys.

Authors:  C P Gibbs; K Nazerian; L F Velicer; H J Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  [Structure and function of virus-induced antigens in cultured cells infected with Merek's disease and turkey herpes viruses. II. Isolation of intracellular antigens from infected cells (author's transl)].

Authors:  O R Kaaden
Journal:  Med Microbiol Immunol       Date:  1977-10-07       Impact factor: 3.402

10.  Marek's disease virus serotype-1 antigens A and B and their unglycosylated precursors detected by Western blot analysis of infected cells.

Authors:  I Davidson; M Malkinson; Y Becker
Journal:  Virus Genes       Date:  1988-10       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.